Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe update shows a minor revision from v3.2.0 to v3.3.2; no substantive content or feature changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe general government funding/operating status notice has been removed, but core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedCore study data such as the title, condition, objectives, eligibility criteria, and outcome measures appear unchanged; observed differences are limited to layout adjustments and minor wording edits. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check69 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; no other core content or pricing changes were detected.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.